More tools:Markets·Screener·Research·Chat

MDxHealth SA Ordinary Shares (MDXH) Financial Statements

MDxHealth SA Ordinary Shares
SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
FIGI BBG001SF8932
XNAS · usd
0.71▼ 0.03 (-4.66%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close0.75
Day's Range0.70 – 0.75
52-Week Range0.40 – 5.33
Volume325.8K
Avg Volume11.5M
Share Statistics
Shares Outstanding
Employees364
ExchangeXNAS
Listed2008-02-14
Share count as of December 31, 2025
Loading Income Statement…
Key questions about MDxHealth SA Ordinary Shares (MDXH)
What is MDxHealth SA Ordinary Shares's Market Cap?
MDxHealth SA Ordinary Shares's Market Cap is $36.6M, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's Enterprise Value?
MDxHealth SA Ordinary Shares's Enterprise Value is $83.8M, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's Price / Sales?
MDxHealth SA Ordinary Shares's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's EV / Revenue?
MDxHealth SA Ordinary Shares's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's Revenue (TTM)?
MDxHealth SA Ordinary Shares's Revenue (TTM) is $107.9M, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's Net Income (TTM)?
MDxHealth SA Ordinary Shares's Net Income (TTM) is -$33.5M, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's Diluted EPS (TTM)?
MDxHealth SA Ordinary Shares's Diluted EPS (TTM) is -0.65, based on as-reported figures from SEC (XBRL) filings.
What is MDxHealth SA Ordinary Shares's Net Debt?
MDxHealth SA Ordinary Shares's Net Debt is $47.2M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Profit or loss [abstract]
Revenues
Cost of sales (exclusive of amortization of intangible assets)
Gross profit
Research and development expenses
Selling and marketing expenses
General and administrative expenses
Amortization of intangible assets
Other operating income (expense), net
Operating loss
Financial income
Financial expenses
Loss before income tax
Income tax benefit (expense)
Loss for the year attributable to owners of the parent
Loss per share attributable to owners of the parent
Basic (in Dollars per share)
Diluted (in Dollars per share)